Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDBio-Rad Laboratories Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 2 | $1.97 | $1.98 | $1.97 |
| Q2 2026 | 2 | $1.74 | $1.75 | $1.75 |
| Q3 2026 | 1 | $2.22 | $2.23 | $2.23 |
| Q4 2026 | 1 | $3.01 | $3.03 | $3.02 |
| Q1 2027 | 1 | $3.09 | $3.11 | $3.10 |
| Q2 2027 | 1 | $2.69 | $2.71 | $2.70 |
| Q3 2027 | 1 | $2.69 | $2.71 | $2.70 |
| Q4 2027 | 1 | $2.90 | $2.92 | $2.91 |
| Q1 2028 | 1 | $3.33 | $3.36 | $3.34 |
| Q2 2028 | 1 | $2.96 | $2.98 | $2.97 |
| Q3 2028 | 1 | $2.96 | $2.98 | $2.97 |
| Q4 2028 | 1 | $3.19 | $3.21 | $3.20 |
Bio-Rad Laboratories Inc. Earnings Date And Information
Bio-Rad Laboratories Inc. last posted its earnings results on Tuesday, August 4th, 2026. The company reported $2.62 earnings per share for the quarter, topping analysts' consensus estimates of $1.75 by $0.87. The company had revenue of 651.00 M for the quarter and had revenue of 2.58 B for the year. Bio-Rad Laboratories Inc. has generated $28 earnings per share over the last year ($27.87 diluted earnings per share) and currently has a price-to-earnings ratio of 42.9. Bio-Rad Laboratories Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Bio-Rad Laboratories Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/04/2026 | Q2 2026 | $1.75 | $13.89 | 12.14 | $623.99 M | $651.00 M |
| 04/30/2026 | Q1 2026 | $1.97 | -$19.55 | -21.52 | $589.91 M | $592.10 M |
| 02/12/2026 | Q4 2025 | N/A | $26.69 | N/A | $688.81 M | $693.20 M |
| 10/29/2025 | Q3 2025 | $2.30 | -$12.70 | -15 | $652.24 M | $653.00 M |
| 07/31/2025 | Q2 2025 | $1.93 | $11.67 | 9.74 | $615.20 M | $651.60 M |
| 05/01/2025 | Q1 2025 | $1.73 | $2.29 | 0.56 | $573.27 M | $585.40 M |
| 02/14/2025 | Q4 2024 | N/A | -$25.57 | N/A | $679.29 M | $667.48 M |
| 10/31/2024 | Q3 2024 | N/A | $23.37 | N/A | $628.18 M | $649.73 M |
| 08/02/2024 | Q2 2024 | N/A | -$76.26 | N/A | $645.79 M | $638.48 M |
| 05/08/2024 | Q1 2024 | N/A | $13.46 | N/A | $619.09 M | $610.82 M |
| 02/16/2024 | Q4 2023 | N/A | $12.15 | N/A | $685.00 M | $681.18 M |
| 10/27/2023 | Q3 2023 | N/A | $3.65 | N/A | $689.50 M | $632.12 M |
| 08/04/2023 | Q2 2023 | N/A | -$39.59 | N/A | $697.96 M | $681.11 M |
| 05/05/2023 | Q1 2023 | N/A | $2.33 | N/A | $689.96 M | $676.84 M |
| 02/17/2023 | Q4 2022 | N/A | $27.89 | N/A | $742.26 M | $730.29 M |
| 10/28/2022 | Q3 2022 | N/A | -$5.53 | N/A | $679.94 M | $680.80 M |
| 07/29/2022 | Q2 2022 | N/A | -$31.12 | N/A | $682.62 M | $691.10 M |
| 04/29/2022 | Q1 2022 | N/A | -$112.58 | N/A | $672.63 M | $700.06 M |
| 02/11/2022 | Q4 2021 | N/A | -$52.59 | N/A | $730.26 M | $732.77 M |
| 10/29/2021 | Q3 2021 | N/A | $131.75 | N/A | $664.57 M | $747.05 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Bio-Rad Laboratories Inc. Earnings: FAQ's
In the previous quarter, Bio-Rad Laboratories Inc. (:BIO) reported $2.62 earnings per share (EPS) to beat the analysts' consensus estimate of $1.75 by $0.87.
The conference call for Bio-Rad Laboratories Inc.'s latest earnings report can be listened to online.
The conference call transcript for Bio-Rad Laboratories Inc.'s latest earnings report can be read online.
Bio-Rad Laboratories Inc. (:BIO) has a recorded annual revenue of $2.58 B.
Bio-Rad Laboratories Inc. (:BIO) has a recorded net income of $759.90 M.Bio-Rad Laboratories Inc. has generated $27.87 earnings per share over the last four quarters.
Bio-Rad Laboratories Inc. (:BIO) has a price-to-earnings ratio of 42.9 and price/earnings-to-growth ratio is -0.15.